ArticleInternational journal of oncology2018

miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2.

Li-Li Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.